Sales of Vaccine Delivery Devices Market Is Set to Increase At A CAGR of 8% by 2032

the global Vaccine Delivery Device market is projected to grow at a compound annual rate (CAGR) of 9.5% between 2022 and 2032. The market is expected to reach US$ 10.25 Bn by the end of 2032. For instance, the UK government invested £1 million from its Global Challenges Research Fund through Medical Research Council to probe the Zika Virus transmission and its source.

In addition, the demand for advanced vaccine delivery devices has increased owing to their application in treatments of influenza, hepatitis A and B, and meningitis, thereby bolstering the market size in the forecast period.

Prospects were further elevated during the COVID-19 pandemic, as it created an urgency for developed and efficient vaccination devices, thereby elevating the market size. In addition, the initiatives taken by various governments and non-government organizations are anticipated to boost the market significantly.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:https://www.factmr.com/connectus/sample?flag=S&rep_id=178?PJ

The growing financial backing from the government and non-governmental organizations has resulted in a slew of new advances in the field, boosting the market's size. The UK government, for example, allocated £1 million from the Global Challenges Research Fund to the Medical Research Council to investigate Zika Virus transmission and source.

Furthermore, the number of diabetic patients worldwide is increasing. According to the World Health Organization, 422 million people globally are affected by the condition, which is expected to increase the market throughout the forecast period.

𝐖𝐡𝐲 𝐢𝐬 𝐀𝐏𝐄𝐉 𝐏𝐫𝐞𝐝𝐢𝐜𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐭𝐡𝐞 𝐅𝐚𝐬𝐭𝐞𝐬𝐭-𝐆𝐫𝐨𝐰𝐢𝐧𝐠 𝐑𝐞𝐠𝐢𝐨𝐧?

Contribution of Developing Nations to Increase Demand for Vaccine Delivery Devices
APEJ is projected to be the fastest-growing region owing to the increasing patient pool. The presence of developing nations such as; India and China is projected to further boost the market in the region.

Moreover, the unmet vaccine demand in the untapped regions is predicted to augment the industry in APEJ in the coming time. Also, the rising geriatric population in the region can notably boost the demand for vaccination, thereby bolstering the market in APEJ. The region is forecast to grow at a CAGR of 12% through 2032.

𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐂𝐨𝐯𝐞𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐕𝐚𝐜𝐜𝐢𝐧𝐞 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐃𝐞𝐯𝐢𝐜𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐒𝐮𝐫𝐯𝐞𝐲

• By Product Type

• Syringes-based Vaccine Delivery Devices
• Jet Injectors-based Vaccine Delivery Devices Market
• Other Vaccine Delivery Device Products

• By Route of Administration

• Subcutaneous Vaccine Delivery Devices
• Intramuscular Vaccine Delivery Devices
• Intradermal Vaccine Delivery Devices
• Other Vaccine Delivery Devices

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞

The key players of the global vaccine delivery devices market adopt strategies such as; collaboration, partnership, and acquisitions.
• In April 2020, Zealand Pharma acquired Valeritas Holdings, a U.S based medical company for a price of USD 23 Mn.
• In November 2021, Gerresheimar entered into a partnership with Midas Pharma for a new auto injector. The partnership comprises of the development and marketing of new generation auto injector.
• In August 2021, the Vaccine developer Serum Institute of India acquired a 50% stake in pharma packaging company Schott Kaisha for an amount that was not disclosed. Schott AG is a Germany-based player that manufactures vials, syringes, and cartridges.

𝐊𝐞𝐲 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐕𝐚𝐜𝐜𝐢𝐧𝐞 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐃𝐞𝐯𝐢𝐜𝐞 𝐌𝐚𝐫𝐤𝐞𝐭

• Becton Dickinson & Company
• PharmaJet Inc.
• Valeritas Holdings Inc.
• Vaxxas Pty. Ltd
• Gerresheimer AG
• Schott AG
• Antares Pharma, Inc.
• 3M Company

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲

• By product type, syringes are likely to be most lucrative, accumulating US$ 900 Mn in value
• Sales of intramuscular vaccine delivery devices to reach a value of US$ 1 Bn by 2022
• North America to be a potential revenue hub, forecast to incline at a 10% CAGR
• APEJ to be the most opportunistic market, flourishing at 12% CAGR from 2022-2032
• Global vaccine delivery devices market likely to be valued at over US$ 4 Bn by 2022-end

𝐆𝐞𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=178?PJ

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

About Fact.MR:

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.